Monty K Allen insider trades: Iradimed (IRMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Monty reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | IRMD | ↓ Sell | 1,419 | $86.41 | $123K | Direct | Sep 8, 2026 (5d) |
| Feb 13, 2026 | IRMD | ↓ Sell | 1,000 | $100.26 | $100K | Direct | Feb 13, 2026 (0d) |
| Aug 6, 2025 | IRMD | ↓ Sell | 1,102 | $69.10 | $76K | Direct | Aug 6, 2025 (0d) |
| Jun 3, 2024 | IRMD | ↓ Sell | 1,947 | $43.37 | $84K | Direct | Jun 4, 2024 (1d) |
| May 10, 2023 | IRMD | ↓ Sell | 2,786 | $46.03 | $128K | Direct | May 10, 2023 (0d) |
| Aug 4, 2022 | IRMD | ↓ Sell | 3,072 | $37.71 | $116K | Direct | Aug 5, 2022 (1d) |
| Feb 24, 2022 | IRMD | ↓ Sell | 1,000 | $47.01 | $47K | Direct | Feb 24, 2022 (0d) |
| Aug 3, 2021 | IRMD | ↓ Sell | 4,597 | $34.08 | $157K | Direct | Aug 4, 2021 (1d) |
| Aug 6, 2020 | IRMD | ↓ Sell | 9,062 | $22.22 | $201K | Direct | Aug 7, 2020 (1d) |
| Feb 19, 2020 | IRMD | ↓ Sell | 5,000 | $26.05 | $130K | Direct | Feb 20, 2020 (1d) |
| Nov 4, 2019 | IRMD | ↓ Sell | 8,038 | $24.74 | $199K | Direct | Nov 5, 2019 (1d) |
| Mar 5, 2019 | IRMD | ↓ Sell | 10,000 | $25.39 | $254K | Direct | Mar 6, 2019 (1d) |
| Aug 9, 2018 | IRMD | ↓ Sell | 4,347 | $27.04 | $118K | Direct | Aug 10, 2018 (1d) |
| May 2, 2018 | IRMD | ↓ Sell | 1,899 | $17.94 | $34K | Direct | May 4, 2018 (2d) |
| Dec 4, 2017 | IRMD | ↓ Sell | 1,898 | $13.95 | $26K | Direct | Dec 6, 2017 (2d) |
| Jun 14, 2016 | IRMD | ↓ Sell | 2,275 | $20.00 | $46K | Direct | Jun 14, 2016 (0d) |
| Jun 13, 2016 | IRMD | ↓ Sell | 2,100 | $20.44 | $43K | Direct | Jun 14, 2016 (1d) |
| Aug 25, 2015 | IRMD | ↓ Sell | 6,250 | $24.85 | $155K | Direct | Aug 25, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRMD insiders
Open-market trades in the last 12 months
About Monty K Allen's insider trades
Monty K Allen is a director at Iradimed (IRMD). Since Aug 25, 2015, Monty has reported no open-market purchases and 18 sales worth $2.0M on SEC Form 4. In the last 12 months: 2 sales ($223K).
Their filings also include option exercises (20 filings), grants and awards (17 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.